Abstract N-3 long chain polyunsaturated fatty acids (n-3LC-PUFA) are essential components of vertebrate membrane lipids and are crucially deficient in modern Western diets. The main human dietary source for n-3LC-PUFA is fish and seafood, and over 50% of global fish production is currently supplied by aquaculture. However, increasing pressure to include vegetable oils, which are devoid of n-3LC-PUFA, in aquaculture feeds reduces their content in farmed fish flesh. The aim of this study was to measure the heritability and infer mechanisms determining flesh n-3LC-PUFA content in Atlantic salmon. This was achieved by analysing flesh lipid parameters in 48 families of Atlantic salmon and by measuring differences, by high density microarray, in hepatic mRNA expression in families with high and low flesh n-3LC-PUFA. The results show that flesh n-3LC-PUFA composition is a highly heritable trait (h 2 = 0.77±0.14). Gene ontology analysis of differentially expressed genes indicate increased hepatic lipid transport, likely as very low density lipoprotein (VLDL), and implicate increased activity of a transcription factor, hepatic nuclear factor 4α (HNF4α), possibly as a result of family differences in transforming growth factor β1 (Tgfβ1) signalling. This study paves the way for identification of quantitative trait loci and gene interaction networks that are associated with flesh n-3LC-PUFA composition, which will assist the sustainable production of Atlantic salmon and provide optimal levels of critical nutrients for human consumers.
Introduction
Humans, and probably all other vertebrates require preformed dietary 18:2 n-6 (linoleic acid, LA) and α−18:3n-3 (α−linolenic acid, ALA) polyunsaturated fatty acids (PUFA) (Burr and Burr, 1930; Rivers and Frankel, 1981; Cowey and Cho, 1993) . These essential fatty acids cannot be biosynthesised or interconverted in vertebrates, and are primarily derived from plants. LA and ALA have vital functions in themselves, and in turn act as precursors for the long chain PUFA (LC-PUFA) 20:4n-6 (arachidonic acid, ARA), 20:5n-3 (eicosapentenoic acid, EPA) and 22:6n-3 (docosahexanoic acid, DHA). LC-PUFA are essential components of cell membranes, particularly in nervous tissue and their biosynthesis from LA and ALA can be carried out by mammals, although evidence suggests that the process of EPA and particularly DHA biosynthesis from ALA is very low in humans (Burdge and Calder, 2005) . The biosynthetic pathway involves consecutive desaturation and elongation reactions that convert LA to ARA and ALA to EPA and DHA. The two main enzyme families involved in these conversions are the elongases of very long fatty acids (Elovl) and the fatty acyl desaturases (Fad) (Cook and McMaster, 2004) .
Modern Western diets have an excess of n-6 PUFA, primarily LA, and because n-6 fatty acids and n-3 fatty acids cannot be interconverted in vertebrates, this has led to an increase in the tissue ratio of n-6 to n-3 LC-PUFA. Such imbalances in n-6/n-3 ratios have been linked to several chronic diseases that are particularly prevalent in Western societies including cardiovascular, inflammatory and neurological problems (Calder, 2006) . One way of addressing this n-6/n-3 imbalance is to increase the levels of n-3 PUFA and especially n-3LC-PUFA in the diet of humans. Since the conversion of ALA to LC-PUFA has been found to be relatively low in humans, an increase in dietary n-3LC-PUFA would be of most benefit. In human diets seafood, particularly oily fish, is the major source of n-3LC-PUFA, and in Western countries minimum consumption levels of fish have been recommended by various health advisory bodies (Scientific Advisory Committee on Nutrition, 2004; Lichtenstein et al., 2006; Scientific Advisory Committee on Nutrition, 2004) .
Currently aquaculture produces about 50% of all fish and seafood for human consumption globally. The formulation of feed is critical for finfish aquaculture, ensuring optimal growth rates and fish welfare, and until recently the bulk feed ingredients have consisted of fish meal and fish oil, extracted from industrial feed-grade capture fisheries. These capture fisheries are now fished at the maximum sustainable limit, and worldwide aquaculture currently consumes the vast majority of the resulting fish meal and oil (Tacon and Metian, 2009) . Therefore, in order to enable the aquaculture sector to grow in line with consumer demand, alternative bulk feed ingredients are being sought. In recent years, terrestrial plant seed meals and oils, such as those derived from processed soy bean or rapeseed have been used to substitute up to 70% of fish meal and oil in Atlantic salmon diets with little or no effects on fish growth rate (Torstensen et al., 2005) . Like humans, fish require dietary PUFA and LC-PUFA. LC-PUFA are abundant in fish oil, having accumulated ultimately from the phytoplanktonic organisms which form the base of marine food webs (Brett and Muller-Navarra, 1997) . However, the flesh of fish fed diets containing plant oils have low levels of the most beneficial n-3LC-PUFA, DHA and EPA, and this deficiency compromises the quality and health benefits of the product (Torstensen et al., 2005) .
Unlike some other fish species, Atlantic salmon have the capacity to biosynthesise n-3 and n-6LC-PUFA, expressing, predominantly in liver, the ∆5fad, ∆6fad and elovl genes necessary. Furthermore, these genes and LC-PUFA biosynthesis are up-regulated after plant oil feeding (Tocher et al., 2001; Zheng et al., 2005a; Leaver et al., 2008; Morais et al., 2009) . Nevertheless, the increase in n-3LC-PUFA biosynthesis during plant oil feeding is not sufficient to adjust flesh n-3LC-PUFA levels to the levels normally expected after fish oil feeding (Leaver et al., 2008) . The production of strains of farmed animals with enhanced flesh n-3LC-PUFA would be of great value, and there is evidence from mammals and birds that there is a heritable genetic component governing capacity to biosynthesise and/or deposit LC-PUFA (De Smet et al., 2004; Karamichou et al., 2006; Khang et al., 2007) The aim of this study was to assess whether there is a heritable component in flesh LC-PUFA levels in families of Atlantic salmon fed plant oil, and whether flesh LC-PUFA variability can be explained by gene expression in the liver, the predominant site of LC-PUFA biosynthesis in Atlantic salmon.
Methods

Fish, diet and sampling
The fish chosen for analysis were from 48 families, randomly selected from a cohort of 200 families that were siblings to the broodstock fish of Landcatch Natural Selection (Alloa, Scotland). These fish were spawned in December 2004, subsequently incubated and hatched in 2005, and maintained as individual families in separate freshwater tanks at Landcatch (Ormsary, Lochgilphead, Scotland). The fish were fed a commercial salmon feed until they had reached an average weight of 71±9 in April 2006. Twenty-five smolts from each of the 48 families were transferred to a single seawater tank in April 2006 and, after acclimation, were grown for 12 weeks on an experimental diet with reduced fishmeal, and fish oil replaced with a blend of vegetable oils (50% rapeseed oil, 30% palm oil and 20% camelina oil) as described in detail previously (Petropoulos et al., 2009) . The fatty acid composition of the experimental diet is given in Table 1 . All fish were tagged with electronic transponders (Pit tags) to allow individual growth to be monitored, with initial fish weights and lengths recorded at tagging. Fish were maintained at ambient temperature and under ambient photoperiod. At harvest, after 12 weeks of feeding the experimental diet, fish weight and length were recorded, and a flesh sample (Norwegian Quality Cut) collected, frozen on dry ice and stored at -20 o C until analysis. Liver samples were taken from each individual fish and immediately frozen in liquid nitrogen and stored at -80 o C prior to RNA extraction.
Lipid and fatty acid analysis
De-boned and skinned flesh samples of equal weight from each fish were combined into 4 pools per family as described previously (Torstensen et al., 2005) . Within each family the number of fish per pool was constant, ranging from one to four, with a an overall mean of 2.17 fish per pool. Total lipids were prepared according to the method of Folch et al. (1957) with lipid content determined gravimetrically. Fatty acid methyl esters (FAME) were prepared by acid-catalysed transesterification of total lipids with 19:0 as internal standard according to the method of Christie (2003). Extraction and purification of FAME was performed as described previously (Tocher and Harvie, 1988) . FAME were separated and quantified by gas-liquid chromatography using a (Ackman, 1980) . Data were collected and processed using the Chromcard for Windows (version 2.00) computer package (Thermoquest Italia S.p.A., Milan, Italy). Total n-3 LC-PUFA (≥ C20 and ≥ 3 double bonds, i.e. mainly 20:4, 20:5, 22:5 and 22:6) content was expressed in relative (percentage of total fatty acids) and absolute (mg fatty acid /100 g flesh) terms.
Heritability Estimates
Heritabilities for three traits, total flesh lipid level (g/100g flesh), percentage n-3LC-PUFA and total n-3LC-PUFA (mg/100g flesh) were estimated by residual maximum likelihood techniques using the ASReml Package (Gilmour et al., 2006) . Input data were the mean trait values for each pool of fish for each family. Variance component analyses of these data yields between-family and within-family variance components for each trait. Accounting for the full-sib family structure, and assuming maternal effects are negligible, the between-family variance is an estimate of σ 2 g /2 and the withinfamily variance is an estimate of σ 2 g /2n + σ 2 e /n, where σ 2 g is the additive genetic variance, σ 2 e is the residual variance and n is the harmonic mean number of fish per pool, which in this case was 1.8. Rearranging these terms allows the heritability (i.e. σ 2 g /(σ 2 g +σ 2 e )) and its standard error to be inferred.
Microarrays, Probe Preparation, Hybridization and Data Collection
Eight families were selected for transcriptomic analysis. The selection criteria ranked families in pairs, each pair with the same total flesh lipid level but with significantly different total n-3LC-PUFA levels, scored as high and low (Table 2 ). This produced a range of total lipid levels and a range of total flesh n-3LC-PUFA levels. Liver was chosen as the target organ because it integrates overall body lipid uptake, dispersion and metabolism and is a major site of n-3LC-PUFA biosynthesis, whereas PUFA biosynthesis is virtually undetectable in salmon muscle tissue (Zheng et al., 2005a) .
Frozen liver samples (c. 100 mg) from each individual fish (n=48) were immediately homogenised in 10 volumes of TriReagent (Sigma, Poole, UK). Total RNA was prepared according to the manufacturer's standard protocol. Following spectrophotometric quantitation and quality checking by agarose gel electrophoresis, equal quantities of RNA from each of six individuals were pooled to provide one RNA pool per family. The microarray experiment employed a dual label, pooled reference design, the reference comprising equal amounts of RNA from all samples. Labelled samples (methodology detailed below) were hybridised to the Atlantic salmon TRAITS-SGP 17K cDNA microarray v2 (ArrayExpress accession: A-MEXP-1790; originally described by (Taggart et al., 2008) . A dye swap was included in the experimental design. Thus the entire experiment comprised 16 arrays; 8 families × 2 (dye flip).
RNA was reverse transcribed and labelled with either Cy3 or Cy5 using the FAIRPLAY II cDNA labelling kit (Stratagene) according to the manufacturer's instructions. Briefly, 20 μg total RNA was reverse transcribed after being primed with oligo dT. Following reverse transcription the RNA template was hydrolysed using 1M NaOH for 15 min and then neutralised with 1M HCl. The cDNA was ethanol precipitated overnight. The cDNA pellets were washed in 80% ethanol and air-dried before being resuspended in 5 μL 2× coupling buffer (Stratagene Fairplay Kit). Pre-aliquoted Cy3 and Cy5 dyes (GE HealthCare; PA23001, PA25001) were resuspended in 45μL DMSO prior to being added to coupling buffer. Once the cDNA had fully dissolved (after at least 30 min) 5 μL Cy dye suspension was added to each tube and these incubated in the dark for 30 min. To remove unincorporated dye, the labelled cDNA (total volume 10μL) was passed through a DyeEx 2.0 spin column (Qiagen). Dye incorporation was checked by spectrophotometry (NanoDrop ND-1000, NanoDrop Technologies Inc) and by electrophoresis of labelled cDNA on a mini-gel and visualisation by gel scanner (Typhoon Trio, GE Healthcare). For hybridisation, a proportion of each labeled biological replicate and corresponding pooled reference (30 pmol each dye, c. 500 ng cDNA) were combined and total volume was made up to 25 μL with nuclease-free water. After heating the labelled cDNAs at 95ºC for 3 min in a thermocycler, 225 μL of pre-heated (60ºC) hybridisation solution, comprising 185 μL 0.7X UltraHyb buffer (Ambion), 20 μL poly(A) at l0 mg mL -1 (Sigma-Aldrich), 10 μL herring sperm at c. 10 mg mL -1 (Sigma-Aldrich) and 10 μL ultra pure BSA at 10 mg mL -1 (Sigma-Aldrich), was added and the mixture was kept at 60ºC in the dark until being applied to the microarray. Hybridisations (8 slides per day, randomised over two days) were performed in a Lucidea Slidepro semi-automated system (GE Healthcare). Hybridisation mixture (225 µL) was applied to the microarrays previously loaded into Lucidea Slidepro chambers and maintained at 60ºC. Immediately following this, the chamber temperature was raised to 70ºC for 10 mins and then lowered to 42ºC, at which temperature hybridisation was continued for 17 hrs with pulse mixing every 15 mins. Following hybridisation, two automatic washes (800 μL per slide at 8 μL / sec) were performed with 1.0X SSC; 0.1% SDS (wash 1) and 0.3X SSC; 0.2% SDS (wash 2), after which the temperature was lowered to 40ºC. Slides were then removed from the chambers and further manual washes were performed using the EasyDip TM Slide staining system (Canemco Inc.) on an orbital shaker. Two further washes were performed with wash 2 solution for 3 mins each (125 rpm; 45 ºC), followed by 3 x 2 min-washes (125 rpm; 45 ºC) with 0.2X SSC and a final 20 sec dip (room temperature) in 0.1X SSC. Slides were then dried by centrifugation (500 xg for 5 mins) and kept in a dessicator and in the dark before being scanned.
Processed microarray slides were scanned at 10 μm resolution using a Perkin Elmer ScanArrayExpress HT scanner. Laser power was kept constant (80%) and the "auto PMT" function within the acquisition software (v.4) was enabled to adjust PMT for each channel such that less than 0.1% of features were saturated and that the mean intensity ratio of the Cy3 and Cy5 signals was close to one. BlueFuse software (BlueGnome) was then used to identify and quantify features. Following manual spot editing to remove obvious artifactual features and fusion of duplicate spot data (BlueFuse proprietary algorithm), the resulting intensity values and quality annotations, without positive and negative control features, were exported into the GeneSpring GX version 7.3.1 (Agilent Technologies) analysis platform. Dye-flipped data were subject to transformation, normalisation and quality filtering as follows: 1) all raw spot intensity values less than 1 were set to1; 2) a Per Spot and Per Chip Intensity Dependent (Lowess) normalisation was performed using software default values (20% smoothing, cutoff 10); 3) data were filtered using a BlueFuse spot confidence value ≥ 0.1 in ≥ 4 slides and BlueFuse quality >0 in ≥ 4 slides. The experimental hybridizations are archived on the EBI ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) under accession number E-XXXXX (number yet to be assigned). All associated metadata comply with MIAME guidelines.
A list of differentially expressed genes was generated by examining differences between the four families with high percentage n-3LC-PUFA at each total lipid level and the four families showing low n-3LC-PUFA level at the same total lipid level (T-test, p<0.05). The putative identity of cDNAs on the microarray was established by comparing cDNA (EST) sequences to the Refseq database of Genbank using BLASTX homology searching. Similarity scores above e -10 were regarded as providing insufficient evidence for encoded protein identity. Array features were further annotated (e.g. for Gene Ontology) as described previously (Taggart et al., 2008) . The probability that a particular biological process GO term was enriched in the input GO list (All GO annotations in the TRAITS-GS array) compared to the output GO list (all GO annotations in the experimentally altered gene list) was calculated using a hypergeometric distribution model as implemented by GeneSpring GX 7.3.1.
Statistics
Unless otherwise stated, all data are presented as means ± SD (n value as stated). The effects of family on biometry, composition and enzyme activity were analysed by one-way analysis of variance (ANOVA) followed, where appropriate, by Tukey's comparison test. Percentage data and data which were identified as non-homogeneous (Bartlett's test) were subjected to arcsine transformation before analysis. Differences were regarded as significant when P ≤ 0.05.
Results
Flesh n-3LC-PUFA in families
Across all families analysed total lipid levels varied between 3.5 and 6.5 g/100g flesh and the percentage of n-3LC-PUFA in flesh varied between 9.5% and 15.6% of total fatty acids. Comparison of total lipid levels and percentage n-3LC-PUFA showed that these parameters were highly linearly inversely correlated (Table 3 , Fig 1) across all of the 48 families. Final mass was also inversely correlated with percentage n-3LC-PUFA. Absolute n-3LC-PUFA levels were highly correlated with lipid levels and lipid levels were correlated to both initial and final mass (Table 3 ). In contrast there was no evidence of correlation between n-3LC-PUFA level and initial weights, or absolute n-3LC-PUFA during the vegetable oil feeding period.
Nevertheless, it was also apparent that some families with the same total flesh lipid level had significantly different percentage n-3LC-PUFA levels, which indicated that variation in n-3LC-PUFA composition may not be entirely due to differences in lipid deposition between families.
Heritabilities
In total 48 families and 416 fish provided data for the heritability analyses, and the inferred heritabilities are shown in Table 4 . These family data indicate that total lipid levels and percentage n-3LC-PUFA are highly heritable, with absolute n-3LC-PUFA levels being moderately heritable. Therefore, in these data a high proportion of the differences seen between individual fish, and between families, are likely to be genetic in origin. Thus, although families show similar total flesh lipid levels, n-LC-PUFA composition is under genetic control.
Microarray
It was not feasible to analyse all 48 families for gene expression using microarrays. Therefore 8 families were selected, and ranked in pairs, with each pair having the same flesh total lipid levels but showing significantly different percentages of n-3LC-PUFA. This allowed a comparison between gene expression profiles associated with high and low n-3LC-PUFA, whilst minimising effects of total lipid deposition on gene expression. This comparison resulted in a list of 1345 genes that were differentially expressed between families with high percentage n-3LC-PUFA and those with low percentage n-3LC-PUFA. Application of false discovery correction (FRD, Benjamini and Hochberg, 1995) resulted in a list of only 13 genes. However, since several of the genes in the output list generated before FDR correction were present as more that one feature (eg apolipoprotein B, GAPDH, PTGS etc) it is reasonable to accept the list of 1345 genes as representative of genuine gene expression differences. To increase the robustness of this uncorrected output list, it was further filtered to exclude any gene with less than a 1.25-fold difference between high and low n-3LC-PUFA, resulting in a list of 151 genes, 96 of which had BLASTX hits above the selected cut-off criterion (< e -10 ) to nr-refseq database entries (Table 5) . Over-represented GO terms associated with this filtered list are presented in Table 6 . Over-represented biological process categories fell into two main groups: transport, including lipid transport and cell cycle genes. This GO analysis should be treated with some caution as it is limited by the incomplete annotation of salmon genes, and is not corrected for false discovery. Nevertheless, investigating in more detail both GO-annotated and GOunannotated gene lists, it is clear that the largest group is involved in lipid transport and lipid metabolism, with plasma liporotein mRNAs (apoB, apoCII, apoA1), cholesterol and phospholipid transport (StarD3 and StarD2), and circulating fatty acid binding proteins (albumin and PTGDS) all having higher hepatic mRNA levels in families with high muscle n-3LC-PUFA. Two important fatty acid metabolism genes, acyl-CoA oxidase and long chain acyl-CoA dehydrogenase were expressed at lower level in families with high percentage n-3LC-PUFA, whilst two glycolytic genes (GAPDH and TPI) were higher in expression. A group of nine genes associated with cell cycle and cell growth were also expressed at lower levels in high n-3LC-PUFA families, whilst extracellular matrix proteins with cell growth functions were increased (LTBP1 and ECM1). LTPB1 was the gene with the highest expression differences between high and low n-3LC-PUFA families, and is responsible for tethering latent TGFβ1, an important growth regulating cytokine, to the extracellular matrix (Massague, 1998) . A group of 14 differentially expressed genes are involved in transcription and transcriptional regulation, some higher and some lower in high n-3LC-PUFA families.
Discussion
Comparison of 48 randomly selected families of Atlantic salmon indicates that the level of n-3LC-PUFA, expressed as a percentage of total fatty acids in muscle, is a highly heritable trait. This and similar traits have also been measured in terrestrial livestock (Karamichou et al., 2006; De Smet et al., 2004 ) and significant heritabilities also demonstrated. However, the heritability for the percentage flesh n-3LC-PUFA in salmon is considerably higher than for other livestock. It is also apparent that total flesh lipid level also has a high heritable component, and this trait is also well known to be heritable in a variety of farm animal species (Kerry and Ledward, 2009).
Importantly, the absolute level of n-3LC-PUFA in salmon flesh is highly positively correlated with total lipid content because, as the lipid content increases, the content of individual fatty acids, including n-3LC-PUFAs will inevitably increase as well. Both of these parameters were also correlated with growth parameters, intial and final weights. However, the levels of flesh n-3LC-PUFA as a percentage of total fatty acids are inversely correlated with flesh total lipid and with final weight. This is because in the experiment described here the salmon are being fed diets deficient in n-3LC-PUFA and the lipid deposited in flesh is reflective of the diet content, thus the more lipid deposited, the lower the percentage n-3LC-PUFA. Nevertheless, there was still a large variation in flesh n-3LC-PUFA content between families, even amongst families showing the same total flesh lipid content. Taken together this suggests that families with high flesh n-3LC-PUFA content must either selectively incorporate it into flesh from the small amount still present in the diet, or that the n-3LC-PUFA originates from biosynthesis in either liver or intestine. Liver and intestine are the major sites of synthesis in salmon, muscle biosynthesis being negligible (Tocher et al., 2003) .
Numerous previous studies have demonstrated that n-3 LC-PUFA biosynthesis in both liver and intestine is induced in salmon fed diets deficient in these nutrients (Zheng et al., 2005b; Leaver et al., 2008; Bell et al., 2002; Bell et al., 1997) , and this is due to transcriptional activation of genes for the biosynthetic enzymes (Zheng et al., 2004; Leaver et al., 2008; Morais et al., 2009 ). The driving mechanism for this up-regulation may be the reduced cholesterol content of vegetable oil-based diets, which results in activation of SREBP transcription factors and an increase in mRNA levels of genes involved in cholesterol biosynthesis as well as in LC-PUFA biosynthesis (Leaver et al., 2008; Zheng et al., 2009 ). The results of the current study indicate that the mRNA levels of hepatic desaturases and elongases, and also of cholesterol biosynthetic enzymes were not different between families, presumably indicating that the vegetable oil diet had similarly increased mRNAs for these proteins in all fish. However there was a clear increase in hepatic mRNA levels for lipid transport genes in families with a high percentage of n-3LCPUFA in flesh, as well as differences in expression of cell cycle and growth related genes, and in genes for secretory pathways and various secreted proteins of the plasma and extracellular matrix.
Although there are limitations to the identification of fish-mammal homologues (or paralogues) based on BLAST, and limitations in the specificity (due to the possibility of cross-hybridisation of related genes) of cDNA arrays such as that used here, it may be possible to infer potential mechanisms for these differences between high and low LC-PUFA families. For example, in mammals several studies have shown that the nuclear receptor HNF4α (NR2A1) is a major transcriptional regulator of many of the genes listed, particularly the lipid transport lipoproteins, apoB, apoC1 and apoA1, and also of Sepp1 and various members of the Serpin protease inhibitors (Boj et al., 2006; Odom et al., 2004; Kel et al., 2008; Naiki et al., 2002) , all of which are among the genes expressed more highly in high LC-PUFA families compared to low. Studies of mice defective for HNFα have shown that this transcription factor is absolutely required for constitutive expression of lipid transport genes responsible for VLDL secretion in liver (Hayhurst et al., 2001) . One source of the high n-3LC-PUFA in flesh of some families is presumably liver biosynthesis, because these fatty acids are deficient in the diet. This newly synthesised LC-PUFA must be delivered to tissues as a component of lipoproteins, principally VLDL, synthesised in liver, and it is therefore possible that variations in the activity or expression of hepatic HNF4α can influence flesh n-3LC-PUFA content.
It is notable that there are significantly differentially expressed genes with homologues whose products are known to form regulatory interactions with HNFα in mammals. The gene with the greatest fold change (×3.55) of expression in high compared to low n-3LC-PUFA is LTBP1 (which encodes latent transforming growth factor beta binding protein 1). This protein binds Tgfβ1 (transforming growth factor β1) and tethers it in latent form to the extracellular matrix, this being a crucial step in regulating Tgfβ1 function (Ramirez and Rifkin, 2009 ). Tgfβ1 is a cytokine with a myriad of functions, including regulation of extracellular matrix synthesis, cell cycle progression and differentiation, as well as being important in cardiovascular, neoplastic and fibrotic disease processes (Massague, 1998) . Tgfβ1 has also been specifically identified as a down-regulator of HNF4α activity, through activation of SMAD signalling networks (Chou et al., 2003; Cicchini et al., 2006) , thus suggesting that LTBP1 might indirectly affect HNFα activity, by virtue of its regulatory interaction with Tgfβ1. Also relevant is the appearance of Snai1 whose expression is reduced in high LC-PUFA families. Snai1 encodes a gene for a zinc finger transcription factor which also downregulates HNF4α expression (Cicchini et al., 2006) and is involved in some of the same cellular processes as TGF1β. It is also notable, with regard to the actions of TGFβ1 and Snai1, that the mRNA expression of a group of genes involved in cell cycle progression are decreased in high n-3LC-PUFA salmon families, and a group which encode extracellular matrix components, including LTBP1 are increased.
In addition to the increased expression of lipid transport genes in the livers of salmon families with high flesh n-3LC-PUFA, there are also two genes that are instrumental in fatty acid metabolism and which are decreased in these families. These genes encode acyl-CoA oxidase (ACOX1) and a long chain acyl CoA dehydrogenase (ACADL). Since these enzymes can metabolise n-3LC-PUFA, a reduction in levels might lead to an increase in supply in the liver, and thus also increase availability for export to other tissues.
A variety of genes whose products are involved in transcription, protein processing and transport, or are involved in the regulation of these pathways, are differentially expressed when comparing high and low n-3LC-PUFA families. Since it is appears that a number of lipid transport, metabolic and cell cycle process genes differ in expression, it could be surmised that any resulting differences in these transcriptional and protein processing pathways were associated with the specific requirements of lipid transport, metabolism and growth.
In conclusion this study has established that n-3LC-PUFA level is a highly heritable trait in Atlantic salmon, and that there are specific hepatic mRNA expression patterns associated with high flesh n-3LC-PUFA, which indicate possible mechanisms for family-dependent deposition in flesh. Thus, this study opens the way to identifying quantitative trait loci for n-3LC-PUFA level in Atlantic salmon fed LC-PUFA deficient diets, an important objective given the current constraints on the supply of these valuable fatty acids, and their critical role in human nutrition.
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